MALSU1 (mitochondrial assembly of ribosomal large subunit 1) functions as a key regulatory factor in mitochondrial ribosome biogenesis and translation control. The protein serves as a quality control mechanism by preventing premature association of the 28S and 39S ribosomal subunits through interaction with mitochondrial ribosomal protein uL14m (MRPL14), effectively blocking formation of intersubunit bridge B8 1. MALSU1 is recruited to the mitoribosome large subunit during late-stage assembly, where it works alongside other biogenesis factors including MTERF4, NSUN4, and GTPBP10 2 3. The protein functions as a ribosomal silencing factor that negatively regulates mitochondrial translation when added to isolated ribosomal subunits 1. Mechanistically, MALSU1 is essential for maintaining mitochondrial respiratory chain complex activities, cellular ATP levels, and mitochondrial respiration 4. Disease relevance includes associations with neurodegenerative conditions, where elevated MALSU1 expression increases Parkinson's disease risk 5 6, and overexpression contributes to axon degeneration during neurodevelopment 7. In cancer, increased MALSU1 expression correlates with poor prognosis in triple-negative breast cancer and promotes doxorubicin resistance 4. Clinically, MALSU1 represents a potential therapeutic target, as its modulation through tetracyclines can promote cell survival by suppressing ER stress 1.